Kala Bio Inc Expected To Post A Loss Of $2.15 A Share: Earnings Preview

KALA BIO

03/11/2023 15:25

* KALA BIO Inc  KALA.OQ   KALA.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The Arlington Massachusetts-based  company is expected to
report
 a 98.4% increase in revenue to $833.33 thousand from $420
thousand a year ago, according to the mean estimate from 3
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for KALA BIO Inc is for
a
loss of $2.15 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for KALA BIO
Inc is
$27​, above​ its last closing price of $6.88. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -2.82       -3.19      -4.36     Missed  -36.8
 Mar. 31 2023  -4.52       -4.43      -6.99     Missed  -57.9
 Dec. 31 2022  -6.64       -6.92      -7.97     Missed  -15.2​
 Sep. 30 2022  -12.00      16.83      19.25     Beat    14.4
 ​​Jun.        -21.83      -20.50     -19.00    Beat    7.3
 30 2022                                                
 Mar. 31 2022  -17.95      -16.90     -22.50    Missed  -33.1​
 Dec. 31 2021  -22.00      -19.87     -34.00    Missed  -71.1
 Sep. 30 2021  -21.36      -21.50     -21.50    Met     0
 This summary was machine generated November 3 at 15:25 GMT.  All
figures in US dollars  unless otherwise stated